Literature DB >> 18391002

Inheritance of immune polarization patterns is linked to resistance versus susceptibility to Cryptococcus neoformans in a mouse model.

Gwo-hsiao Chen1, David A McNamara, Yadira Hernandez, Gary B Huffnagle, Galen B Toews, Michal A Olszewski.   

Abstract

Genetic background variation between inbred strains accounts for different levels of susceptibility to Cryptococcus neoformans in the mouse infection model. To elucidate the inheritance of immunophenotypic traits and their associations with clearance outcomes during cryptococcal infection, we compared C57BL/6, BALB/c, and their first-generation hybrid, CB6F1 (F1), mice. Mice from each group were infected with C. neoformans (10(4) CFU) and analyzed at weekly intervals over a 6-week period. BALB/c mice progressively cleared the cryptococcal infection in the lungs and showed a Th1-skewed immune response: a Th1-shifted cytokine profile, modest lung pathology, and no significant elevation in the systemic immunoglobulin E (IgE) level. In contrast, C57BL/6 mice developed a chronic infection with a Th2-skewed immune response: a Th2-shifted cytokine profile, pulmonary eosinophilia, severe lung pathology, elevated serum IgE, fungemia, and cryptococcal dissemination in the central nervous system. F1 mice demonstrated intermediate resistance to C. neoformans, with a stronger resemblance to the immunophenotype of the resistant (BALB/c) mice. F1 mice also demonstrated enhanced pulmonary recruitment of lymphocytes, especially CD8(+) T cells, in comparison to both parental strains, suggesting positive heterosis. We conclude that the inheritance of traits responsible for early cytokine induction in the infected lungs and dendritic-cell maturation/activation status in draining nodes is responsible for the intermediate immune response polarization and clearance outcome observed initially in the lungs of F1 mice. The enhanced pulmonary lymphocyte recruitment could be responsible for a gradual shutdown of the undesirable Th2 arm of the immune response and subsequently improved anticryptococcal resistance in F1 mice.

Entities:  

Mesh:

Year:  2008        PMID: 18391002      PMCID: PMC2423067          DOI: 10.1128/IAI.01143-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection.

Authors:  T R Traynor; W A Kuziel; G B Toews; G B Huffnagle
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

2.  Functional defect of natural immune system in an apparent immunocompetent patient with pulmonary cryptococcosis.

Authors:  Massimo Marroni; Eva Pericolini; Elio Cenci; Francesco Bistoni; Anna Vecchiarelli
Journal:  J Infect       Date:  2006-05-04       Impact factor: 6.072

3.  The relative susceptibility of mouse strains to pulmonary Cryptococcus neoformans infection is associated with pleiotropic differences in the immune response.

Authors:  Oscar Zaragoza; Mauricio Alvarez; Andrew Telzak; Johanna Rivera; Arturo Casadevall
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

4.  Distinct compartmentalization of CD4+ T-cell effector function versus proliferative capacity during pulmonary cryptococcosis.

Authors:  Dennis M Lindell; Thomas A Moore; Roderick A McDonald; Galen B Toews; Gary B Huffnagle
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

5.  Immunologic homeostasis during infection: coexistence of strong pulmonary cell-mediated immunity to secondary Cryptococcus neoformans infection while the primary infection still persists at low levels in the lungs.

Authors:  Dennis M Lindell; Megan N Ballinger; Roderick A McDonald; Galen B Toews; Gary B Huffnagle
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

6.  Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis.

Authors:  Gwo-Hsiao Chen; Michal A Olszewski; Roderick A McDonald; Jason C Wells; Robert Paine; Gary B Huffnagle; Galen B Toews
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

7.  Generation of antifungal effector CD8+ T cells in the absence of CD4+ T cells during Cryptococcus neoformans infection.

Authors:  Dennis M Lindell; Thomas A Moore; Roderick A McDonald; Galen B Toews; Gary B Huffnagle
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

8.  Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice.

Authors:  Talar B Kechichian; John Shea; Maurizio Del Poeta
Journal:  Infect Immun       Date:  2007-07-30       Impact factor: 3.441

9.  Modulation of the pulmonary type 2 T-cell response to Cryptococcus neoformans by intratracheal delivery of a tumor necrosis factor alpha-expressing adenoviral vector.

Authors:  Jami E Milam; Amy C Herring-Palmer; Raj Pandrangi; Roderick A McDonald; Gary B Huffnagle; Galen B Toews
Journal:  Infect Immun       Date:  2007-07-23       Impact factor: 3.441

10.  Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans.

Authors:  G B Huffnagle; G H Chen; J L Curtis; R A McDonald; R M Strieter; G B Toews
Journal:  J Immunol       Date:  1995-10-01       Impact factor: 5.422

View more
  58 in total

Review 1.  Induction of protective immunity against cryptococcosis.

Authors:  Karen L Wozniak; Sarah Hardison; Michal Olszewski; Floyd L Wormley
Journal:  Mycopathologia       Date:  2011-12-06       Impact factor: 2.574

2.  Neurovirulence of Cryptococcus neoformans determined by time course of capsule accumulation and total volume of capsule in the brain.

Authors:  A Pool; L Lowder; Y Wu; K Forrester; J Rumbaugh
Journal:  J Neurovirol       Date:  2013-06-04       Impact factor: 2.643

3.  T Cell-Restricted Notch Signaling Contributes to Pulmonary Th1 and Th2 Immunity during Cryptococcus neoformans Infection.

Authors:  Lori M Neal; Yafeng Qiu; Jooho Chung; Enze Xing; Woosung Cho; Antoni N Malachowski; Ashley R Sandy-Sloat; John J Osterholzer; Ivan Maillard; Michal A Olszewski
Journal:  J Immunol       Date:  2017-06-14       Impact factor: 5.422

4.  Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99.

Authors:  Yanmei Zhang; Fuyuan Wang; Kristin C Tompkins; Andrew McNamara; Aditya V Jain; Bethany B Moore; Galen B Toews; Gary B Huffnagle; Michal A Olszewski
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

5.  Lipoxin Signaling in Murine Lung Host Responses to Cryptococcus neoformans Infection.

Authors:  Jennifer K Colby; Katherine M Gott; Julie A Wilder; Bruce D Levy
Journal:  Am J Respir Cell Mol Biol       Date:  2016-01       Impact factor: 6.914

6.  Interleukin-17A enhances host defense against cryptococcal lung infection through effects mediated by leukocyte recruitment, activation, and gamma interferon production.

Authors:  Benjamin J Murdock; Gary B Huffnagle; Michal A Olszewski; John J Osterholzer
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

7.  Virulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain dissemination.

Authors:  Xiumiao He; Daniel M Lyons; Dena L Toffaletti; Fuyuan Wang; Yafeng Qiu; Michael J Davis; Daniel L Meister; Jeremy K Dayrit; Anthony Lee; John J Osterholzer; John R Perfect; Michal A Olszewski
Journal:  Am J Pathol       Date:  2012-07-28       Impact factor: 4.307

8.  Enhanced innate immune responsiveness to pulmonary Cryptococcus neoformans infection is associated with resistance to progressive infection.

Authors:  Loïc Guillot; Scott F Carroll; Robert Homer; Salman T Qureshi
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

9.  Cryptococcal urease promotes the accumulation of immature dendritic cells and a non-protective T2 immune response within the lung.

Authors:  John J Osterholzer; Rishi Surana; Jami E Milam; Gerald T Montano; Gwo-Hsiao Chen; Joanne Sonstein; Jeffrey L Curtis; Gary B Huffnagle; Galen B Toews; Michal A Olszewski
Journal:  Am J Pathol       Date:  2009-02-13       Impact factor: 4.307

10.  Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.

Authors:  Karen L Wozniak; Sailatha Ravi; Sandra Macias; Mattie L Young; Michal A Olszewski; Chad Steele; Floyd L Wormley
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.